What is Intelligent Hearing Systems?
Established in 1983, Intelligent Hearing Systems has evolved into a cornerstone provider of sophisticated hearing evaluation solutions. The company specializes in the development and distribution of high-precision hearing screening devices, diagnostic tools, and advanced clinical simulators. Their product portfolio, which includes automated Auditory Brainstem Response (ABR) and Otoacoustic Emissions (OAE) screening systems, is engineered to meet the rigorous demands of modern clinical environments. By prioritizing portability, cost-effectiveness, and versatility, the organization has successfully integrated its technology into diverse healthcare settings, ensuring that practitioners have access to reliable, data-driven diagnostic capabilities that improve patient outcomes.
The company's market position is defined by its long-standing dedication to technical excellence and customer-centric support. Unlike many emerging entrants in the medical device space, Intelligent Hearing Systems maintains a legacy of innovation that bridges the gap between complex diagnostic requirements and user-friendly clinical workflows. This balance of legacy expertise and modern technological application remains a primary driver of their sustained industry relevance.
How much funding has Intelligent Hearing Systems raised?
Intelligent Hearing Systems has raised a total of $837K across 2 funding rounds:
Debt
$350K
Debt
$487K
Debt (2020): $350K with participation from PPP
Debt (2021): $487K led by PPP
Key Investors in Intelligent Hearing Systems
PPP
Public-Private Partnership
What's next for Intelligent Hearing Systems?
With the recent influx of capital, Intelligent Hearing Systems is well-positioned to accelerate its research and development initiatives, particularly in the realm of automated diagnostic software and next-generation screening hardware. The strategic deployment of these funds will likely focus on expanding the company's global footprint and enhancing its service infrastructure to support a broader range of clinical partners. As the demand for integrated, portable hearing healthcare solutions continues to rise, the firm is expected to leverage its strengthened balance sheet to pursue further market penetration and potentially explore new frontiers in remote diagnostic monitoring. This enterprise-level backing provides the necessary runway to refine existing product lines while maintaining the high standards of clinical accuracy that have become synonymous with the brand.
See full Intelligent Hearing Systems company page
